MedPath

Universidad de los Andes (Chile)

🇨🇱Chile
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.uandes.cl

Calcium Hydroxide, Mineral Trioxide Aggregate and Biodentine (Trademark) as Direct Pulp Capping of Permanent Teeth

Phase 2
Completed
Conditions
Caries
Dental Pulp Exposure
Interventions
Drug: Mineral trioxide aggregate
Drug: Biodentine
First Posted Date
2015-07-09
Last Posted Date
2024-05-30
Lead Sponsor
Universidad de los Andes, Chile
Target Recruit Count
169
Registration Number
NCT02492841
Locations
🇨🇱

Centro de Salud de San Bernardo Universidad de Los Andes, Santiago, Chile

Short-term Effect of 2% Atorvastatin Dentifrice in Periodontal Status.

Phase 2
Completed
Conditions
Chronic Periodontitis
Interventions
Drug: Non-medicated dentifrice
Drug: Medicated 2% atorvastatin dentifrice
First Posted Date
2013-08-27
Last Posted Date
2014-07-28
Lead Sponsor
Universidad de los Andes, Chile
Target Recruit Count
38
Registration Number
NCT01929135
Locations
🇨🇱

CIBRO Universidad de los Andes, Santiago, Región Metropolitana, Chile

🇨🇱

Centro de Salud Universidad de los Andes, San Bernardo, Santiago, Región Metropolitana, Chile

Periodontal Treatment in Non-controlled Type 2 Diabetes Mellitus Patients. Clinical Trial

Not Applicable
Completed
Conditions
Diabetes Mellitus.
Chronic Periodontitis
Interventions
Procedure: conventional periodontal treatment
First Posted Date
2013-07-22
Last Posted Date
2015-12-16
Lead Sponsor
Universidad de los Andes, Chile
Target Recruit Count
87
Registration Number
NCT01904422
Locations
🇨🇱

Joan Alsina Polyclinic, San Bernardo, Metropolitan, Chile

Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy

Phase 1
Completed
Conditions
Dilated Cardiomyopathy
Interventions
Other: Controls
Biological: ucMSC
First Posted Date
2012-12-03
Last Posted Date
2015-06-04
Lead Sponsor
Universidad de los Andes, Chile
Target Recruit Count
30
Registration Number
NCT01739777
Locations
🇨🇱

Universidad de los Andes, Santiago de Chile, Chile

Aldosterone in Diabetic Nephropathy

Phase 4
Conditions
Diabetic Nephropathy
Interventions
First Posted Date
2009-03-27
Last Posted Date
2009-03-27
Lead Sponsor
Universidad de los Andes, Chile
Target Recruit Count
160
Registration Number
NCT00870402
Locations
🇨🇱

University of Los Andes, Santiago, Chile

Cardiovascular Protective Effect of Spironolactone in Hemodialysis

Phase 4
Conditions
Hemodialysis
First Posted Date
2006-01-16
Last Posted Date
2006-01-16
Lead Sponsor
Universidad de los Andes, Chile
Registration Number
NCT00277693
Locations
🇨🇱

Clinica Davila, Santiago, Chile

© Copyright 2025. All Rights Reserved by MedPath